Matthew Bates

8.9k citations

93 papers · 4.3k indexed · 3 hit papers · h-index 34

Impact in

Infectious Diseases top 0.2%
- Tuberculosis Research and Epidemiology
Epidemiology top 1%
- Mycobacterium research and diagnosis
- Pneumonia and Respiratory Infections
- Pneumocystis jirovecii pneumonia detection and treatment
- Cytomegalovirus and herpesvirus research

Papers in ⓘ

Infectious Diseases 71
- Tuberculosis Research and Epidemiology 44
- Viral Infections and Vectors 9
- Parvovirus B19 Infection Studies 7
Epidemiology 53
- Mycobacterium research and diagnosis 18
- Pneumonia and Respiratory Infections 16
- Pneumocystis jirovecii pneumonia detection and treatment 15
- Cytomegalovirus and herpesvirus research 10

Co-authors: Alimuddin Zumla (58 shared papers)Peter Mwaba (40 shared papers)Markus Maeurer (26 shared papers)Nathan Kapata (30 shared papers)Timothy D. McHugh (8 shared papers)Michael Höelscher (16 shared papers)Justin O’Grady (18 shared papers)Ruth McNerney (4 shared papers)
Journals: International Journal of Infectious Diseases (16 papers)Tropical Medicine & International Health (8 papers)The Lancet Infectious Diseases (7 papers)Clinical Infectious Diseases (6 papers)The Lancet Respiratory Medicine (4 papers)
Partner nations: United Kingdom Zambia Germany

In The Last Decade

Matthew Bates

91 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis 2020 · 585 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 New England Journal of Medicine
2018 The Lancet Infectious Diseases
2013 The Lancet Infectious Diseases

Peers

Countries citing papers authored by Matthew Bates

Since Specialization

Citations

This map shows the geographic impact of Matthew Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Bates more than expected).

Fields of papers citing papers by Matthew Bates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Bates. The network helps show where Matthew Bates may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Bates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Bates Line = papers co-authored together Matthew Bates links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Treatment of Highly Drug-Resistant Pulmonary Tuberculosis New England Journal of Medicine ·Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane, Pauline Howell, Daniel E. Everitt, Angela M. Crook, Carl M. Mendel, Erica Egizi, Joanna Moreira, Juliano Timm, Timothy D. McHugh, Genevieve H. Wills, Matthew Bates, Robert Hunt, Christo van Niekerk, Mengchun Li, Morounfolu Olugbosi, Melvin Spigelman Hit paper breakdown →	2020	585
2	Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test The Lancet Infectious Diseases ·Stephen D Lawn, Peter Mwaba, Matthew Bates, Amy S. Piatek, Heather Alexander, Ben J. Marais, Luís E. Cuevas, Timothy D. McHugh, Lynn S. Zijenah, Nathan Kapata, Ibrahim Abubakar, Ruth McNerney, Michael Höelscher, Ziad A. Memish, Giovanni Battista Migliori, Peter Kim, Markus Maeurer, Marco Schito, Alimuddin Zumla Hit paper breakdown →	2013	356
3	Rapid Spread of Zika Virus in The Americas - Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games International Journal of Infectious Diseases ·Eskild Petersen, Mary Wilson, Sok Touch, Brian McCloskey, Peter Mwaba, Matthew Bates, Osman Dar, Frank Mattes, Michael Kidd, Giuseppe Ippolito, Esam I. Azhar, Alimuddin Zumla	2016	263
4	Tuberculosis: advances and challenges in development of new diagnostics and biomarkers The Lancet Infectious Diseases ·Gerhard Walzl, Ruth McNerney, Nelita du Plessis, Matthew Bates, Timothy D. McHugh, Novel N. Chegou, Alimuddin Zumla Hit paper breakdown →	2018	242
5	Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies The Lancet Respiratory Medicine ·Alimuddin Zumla, Jeremiah Chakaya, Rosella Centis, Lia D’Ambrosio, Peter Mwaba, Matthew Bates, Nathan Kapata, Thomas Nyirenda, Duncan Chanda, Sayoki Mfinanga, Michael Höelscher, Markus Maeurer, Giovanni Battista Migliori	2015	159
6	Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment The Lancet Respiratory Medicine ·Sven O. Friedrich, Andrea Rachow, Elmar Saathoff, Kasha P. Singh, Chacha Mangu, Rodney Dawson, Patrick Phillips, Amour Venter, Matthew Bates, Catharina Boehme, Norbert Heinrich, Robert D. Hunt, Martin J. Boeree, Alimuddin Zumla, Timothy D. McHugh, Stephen H. Gillespie, Andreas H. Diacon, Michael Höelscher	2013	128
7	Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects The Lancet Infectious Diseases ·Alimuddin Zumla, Jaffar A. Al‐Tawfiq, Virve I. Enne, Michael Kidd, Christian Drosten, Judith Breuer, Marcel A. Müller, David S.C. Hui, Markus Maeurer, Matthew Bates, Peter Mwaba, Rafaat Alhakeem, Gregory C. Gray, Philippe Gautret, Abdullah A Al-Rabeeah, Ziad A. Memish, Vanya Gant	2014	128
8	Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era International Journal of Infectious Diseases ·Eskild Petersen, Ibrahim Abubakar, Chikwe Ihekweazu, Dominique Heymann, Francine Ntoumi, Lucille Blumberg, Danny Asogun, Victor Mukonka, Swaib A. Lule, Matthew Bates, Isobella Honeyborne, Sayoki Mfinanga, Peter Mwaba, Osman Dar, Francesco Vairo, Maowia M. Mukhtar, Richard Kock, Timothy D. McHugh, Giuseppe Ippolito, Alimuddin Zumla	2018	124
9	Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study The Lancet Infectious Diseases ·Matthew Bates, Justin O’Grady, Markus Maeurer, John Tembo, Lophina Chilukutu, Chishala Chabala, Richard Kasonde, Peter Mulota, Judith Mzyece, Mumba Chomba, Lukundo Mukonda, Maxwell Mumba, Nathan Kapata, Andrea Rachow, Petra Clowes, Michael Höelscher, Peter Mwaba, Alimuddin Zumla	2012	116
10	Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment Journal of Clinical Microbiology ·Isobella Honeyborne, Timothy D. McHugh, Patrick Phillips, Selina Bannoo, Matthew Bates, Nora M. Carroll, Felicity Perrin, Katharina Ronacher, Laura Wright, Paul D. van Helden, Gerhard Walzl, Stephen H. Gillespie	2011	90
11	Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in Zambia Clinical Infectious Diseases ·Ursula A. Gompels, Natasha Larke, Marta Sanz-Ramos, Matthew Bates, Kunda Musonda, Daniela Manno, Joshua Siame, Mwaka Monze, Suzanne Filteau, (unknown)	2012	81
12	Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options The Lancet Infectious Diseases ·Alimuddin Zumla, Ziad A. Memish, Markus Maeurer, Matthew Bates, Peter Mwaba, Jaffar A. Al‐Tawfiq, David W. Denning, Frederick G. Hayden, David S.C. Hui	2014	79
13	Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines Clinical Infectious Diseases ·Marco Schito, Giovanni Battista Migliori, Helen A. Fletcher, Ruth McNerney, Rosella Centis, Lia D’Ambrosio, Matthew Bates, Gibson Kibiki, Nathan Kapata, Tumena Corrah, Jamshed Bomanji, Cristina Vilaplana, Daniel Johnson, Peter Mwaba, Markus Maeurer, Alimuddin Zumla	2015	78
14	Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases Cold Spring Harbor Perspectives in Medicine ·Matthew Bates, Ben J. Marais, Alimuddin Zumla	2015	77
15	Etiology, Antibiotic Resistance and Risk Factors for Neonatal Sepsis in a Large Referral Center in Zambia The Pediatric Infectious Disease Journal ·Mwila Kabwe, John Tembo, Lophina Chilukutu, Moses Chilufya, Francis Ngulube, Chileshe Lukwesa, Monica Kapasa, Virve I. Enne, Hannah Wexner, Lawrence Mwananyanda, Davidson H. Hamer, S. Sinyangwe, Yusuf Ahmed, Nigel Klein, Markus Maeurer, Alimuddin Zumla, Matthew Bates	2016	76
16	Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study The Lancet Infectious Diseases ·Matthew Bates, Victor Mudenda, Aaron Shibemba, Jonas Kaluwaji, John Tembo, Mwila Kabwe, Charles Chimoga, Lophina Chilukutu, Moses Chilufya, Nathan Kapata, Michael Höelscher, Markus Maeurer, Peter Mwaba, Alimuddin Zumla	2015	74
17	Tuberculosis in prisons in sub-Saharan Africa – the need for improved health services, surveillance and control Tuberculosis ·Justin O’Grady, Michael Höelscher, Rifat Atun, Matthew Bates, Peter Mwaba, Nathan Kapata, Giovanni Ferrara, Markus Maeurer, Alimuddin Zumla	2011	68
18	Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa Tropical Medicine & International Health ·Giovanni Battista Migliori, Keertan Dheda, Rosella Centis, Peter Mwaba, Matthew Bates, Justin O’Grady, Michael Höelscher, Alimuddin Zumla	2010	68
19	Predominant human herpesvirus 6 variant A infant infections in an HIV‐1 endemic region of Sub‐Saharan Africa Journal of Medical Virology ·Matthew Bates, Mwaka Monze, H. Bima, Mirriam Kapambwe, David M. Clark, Francis Kasolo, Ursula A. Gompels	2009	66
20	Perspectives on tuberculosis in pregnancy International Journal of Infectious Diseases ·Matthew Bates, Yusuf Ahmed, Nathan Kapata, Markus Maeurer, Peter Mwaba, Alimuddin Zumla	2015	62

About Matthew Bates

Matthew Bates is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Surgery and Molecular Biology, having authored 93 papers that have together received 4.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (44 papers), Mycobacterium research and diagnosis (18 papers), Pneumonia and Respiratory Infections (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (15 papers), Diagnosis and treatment of tuberculosis (14 papers), Cytomegalovirus and herpesvirus research (10 papers), Viral Infections and Vectors (9 papers) and Parvovirus B19 Infection Studies (7 papers). The work is most often cited by research in Infectious Diseases (2.9k citations), Epidemiology (2.5k citations), Virology (212 citations), Molecular Medicine (141 citations) and Surgery (986 citations). Matthew Bates has collaborated with scholars based in United Kingdom, Zambia and Germany. Frequent co-authors include Alimuddin Zumla, Peter Mwaba, Markus Maeurer, Nathan Kapata, Timothy D. McHugh, Michael Höelscher, Justin O’Grady, Ruth McNerney, Ben J. Marais and John Tembo. Their work appears in journals such as International Journal of Infectious Diseases, Tropical Medicine & International Health, The Lancet Infectious Diseases, Clinical Infectious Diseases and The Lancet Respiratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact